Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation - PubMed (original) (raw)
Case Reports
Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation
E M Kaye et al. Ann Neurol. 1988 May.
Abstract
A detailed neuropathological and biochemical study was performed to evaluate the accumulation of ceramide trihexoside within the central and peripheral nervous systems of 2 patients with Fabry's disease. Luxol fast blue-staining lipid was noted in the leptomeninges and in the choroidal stroma; biochemical studies showed increased quantities of ceramide trihexoside in the cerebrospinal fluid. The permeable blood-brain barrier regions of the central and peripheral nervous systems contained increased quantities of ceramide trihexoside. Some central nervous system nuclei associated with autonomic function were also noted to store lipid. Other areas of increased ceramide trihexoside accumulation included specific cortical and brainstem structures. Possible sources for this selective accumulation of ceramide trihexoside within the central and peripheral nervous system include transport of glycolipid from the systemic vascular network and retrograde transsynaptic glycolipid transport.
Similar articles
- Fabry disease: immunocytochemical characterization of neuronal involvement.
deVeber GA, Schwarting GA, Kolodny EH, Kowall NW. deVeber GA, et al. Ann Neurol. 1992 Apr;31(4):409-15. doi: 10.1002/ana.410310410. Ann Neurol. 1992. PMID: 1375013 - Fabry's disease with partially deficient hydrolysis of ceramide trihexoside.
Kobayashi T, Kira J, Shinnoh N, Goto I, Kuroiwa Y. Kobayashi T, et al. J Neurol Sci. 1985 Feb;67(2):179-85. doi: 10.1016/0022-510x(85)90114-5. J Neurol Sci. 1985. PMID: 2984338 - Neurological manifestations in Fabry's disease.
Møller AT, Jensen TS. Møller AT, et al. Nat Clin Pract Neurol. 2007 Feb;3(2):95-106. doi: 10.1038/ncpneuro0407. Nat Clin Pract Neurol. 2007. PMID: 17279083 Review. - [Autonomic dysfunction in metabolic diseases].
Sakakihara Y. Sakakihara Y. Nihon Rinsho. 1992 Apr;50(4):811-7. Nihon Rinsho. 1992. PMID: 1619765 Review. Japanese.
Cited by
- Bridging the Gap Between Vessels and Nerves in Fabry Disease.
Forstenpointner J, Sendel M, Moeller P, Reimer M, Canaan-Kühl S, Gaedeke J, Rehm S, Hüllemann P, Gierthmühlen J, Baron R. Forstenpointner J, et al. Front Neurosci. 2020 Jun 16;14:448. doi: 10.3389/fnins.2020.00448. eCollection 2020. Front Neurosci. 2020. PMID: 32612493 Free PMC article. - Neuropathic pain in a Fabry disease rat model.
Miller JJ, Aoki K, Moehring F, Murphy CA, O'Hara CL, Tiemeyer M, Stucky CL, Dahms NM. Miller JJ, et al. JCI Insight. 2018 Mar 22;3(6):e99171. doi: 10.1172/jci.insight.99171. JCI Insight. 2018. PMID: 29563343 Free PMC article. - Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study.
Cocozza S, Schiavi S, Pontillo G, Battocchio M, Riccio E, Caccavallo S, Russo C, Di Risi T, Pisani A, Daducci A, Brunetti A. Cocozza S, et al. Neuroradiology. 2020 Nov;62(11):1459-1466. doi: 10.1007/s00234-020-02497-7. Epub 2020 Jul 22. Neuroradiology. 2020. PMID: 32700105 Free PMC article. - Chronic meningitis and lacunar stroke in Fabry disease.
Schreiber W, Udvardi A, Kristoferitsch W. Schreiber W, et al. J Neurol. 2007 Oct;254(10):1447-9. doi: 10.1007/s00415-007-0533-8. Epub 2007 Oct 25. J Neurol. 2007. PMID: 17940724 No abstract available. - Altered pupillary light responses are associated with the severity of autonomic symptoms in patients with Fabry disease.
Bitirgen G, Turkmen K, Zengin N, Malik RA. Bitirgen G, et al. Sci Rep. 2021 Apr 14;11(1):8146. doi: 10.1038/s41598-021-87589-x. Sci Rep. 2021. PMID: 33854145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical